Filip Kucera
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD-CAA prevention (KD-CAAP) trial.
Journal: EClinicalMedicine
Published: March 02, 2026
Increasing Number of Clinically Severe Mycoplasma pneumoniae Infections in Children After the COVID-19 Pandemic: A Single-Center Case Series.
Journal: Journal of the Pediatric Infectious Diseases Society
Published: October 04, 2024
One- and Two-year Multidisciplinary Follow-Up of MIS-C at a Tertiary Hospital: A Retrospective Cohort Study.
Journal: The Pediatric infectious disease journal
Published: June 20, 2024
Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol.
Journal: Trials
Published: October 28, 2022
Cardiac outcomes in severe acute respiratory syndrome coronavirus-2-associated multisystem inflammatory syndrome at a tertiary paediatric hospital.
Journal: Cardiology in the young
Published: December 10, 2021
6-month multidisciplinary follow-up and outcomes of patients with paediatric inflammatory multisystem syndrome (PIMS-TS) at a UK tertiary paediatric hospital: a retrospective cohort study.
Journal: The Lancet. Child & adolescent health
Published: March 22, 2021
Severe refractory Kawasaki disease in seven infants in the COVID-19 era.
Journal: The Lancet. Rheumatology
Published: August 25, 2020
T cell phenotype in paediatric heart transplant recipients.
Journal: Pediatric transplantation
Published: December 13, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026